InsidersTradesSigma
Follow the Sunshine Biopharma Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). The latest transaction was disclosed on 11 August 2026 (Attribution). Among the most active insiders: NATAN DAVID. The full history is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Sunshine Biopharma Inc. es una empresa centrada en el desarrollo de fármacos para el tratamiento del cáncer. Cotiza en el NASDAQ bajo el ticker SBFM.